LEIP 2015

Global Report 2015

In 2014, the LeIP Report Card on Lymphomas presented information on clinical trials and therapies that highlighted access issues around the world. This year’s report card builds on that information by providing an overview of the changes in clinical trial availability and therapy access. Not surprisingly, the greatest access to clinical trials and therapies continues to be in the United States of America (USA).

The Lymphoma Coalition’s (LC) goal for the 2015 LeIP Report Card on Lymphomas was to examine access to care through an algorithm of care lens for patients with lymphoma. For the purpose of this report, LC will focus on Hodgkin and mantle cell lymphomas.